Holly Tieu (Luong)

Holly Tieu (Luong) currently serves as the Director of Clinical Operations at Aerium Therapeutics since April 2022, after holding the position of Associate Director in the same field. From 2016 to 2022, Holly worked at Theravance Biopharma US, Inc., first as Associate Director of Platform Services and then as Senior Manager of Global Development Operations. Prior experience includes a role as Project Manager 2 at PRA Health Sciences from 2013 to 2016, where Holly was assigned to Amgen, and a position as Trial Manager for Integrated Clinical Programs at RPS, Inc. between 2009 and 2013, also on assignment at Amgen. Holly began their career at Amgen from 2004 to 2008 as a Senior Clinical Trial Specialist.